IGC Pharma (IGC) Receivables - Net (2011 - 2026)
IGC Pharma (IGC) posted quarterly Receivables - Net of $37000.0 for Q1 2026, up 8.82% year-over-year from $34000.0 in Q1 2025, and up 208.33% quarter-over-quarter from $12000.0 in Q4 2025.
IGC Pharma (IGC) Receivables - Net (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Receivables - Net for 16 consecutive years, with $37000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net rose 8.82% year-over-year to $37000.0; the TTM figure through Mar 2026 stood at $37000.0 (up 8.82% YoY), while the FY2026 annual figure was $37000.0, up 8.82% from the prior year.
- Receivables - Net improved to $37000.0 in Q1 2026 per IGC's latest filing, from $12000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $251000.0 in Q4 2022 and bottomed at $12000.0 in Q4 2025.
- Historically, Receivables - Net has averaged $96705.9 across 5 years, with a median of $87000.0 in 2025.
- Annual changes were most pronounced in 2024 — Receivables - Net tumbled 87.56% — and 2025, when it jumped 210.71%.
- IGC Pharma's Receivables - Net stood at $251000.0 in 2022, then tumbled by 63.35% to $92000.0 in 2023, then plunged by 46.74% to $49000.0 in 2024, then slumped by 75.51% to $12000.0 in 2025, then surged by 208.33% to $37000.0 in 2026.
- Business Quant data shows IGC's Receivables - Net at $37000.0 in Q1 2026, $12000.0 in Q4 2025, and $41000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - |
| 10 | IGC Pharma | 28.18 Mn | 27.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,000.00 |
| Mar 31, 2026 | 37,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 39,000.00 |
| Mar 31, 2024 | 39,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Dec 31, 2023 | 92,000.00 |